0
0
0
Transparency in CFPB Cost-Benefit Analysis Act
12/29/2022, 11:03 PM
Summary of Bill HR 7412
Bill 117 HR 7412, also known as the Transparency in CFPB Cost-Benefit Analysis Act, aims to increase transparency and accountability within the Consumer Financial Protection Bureau (CFPB). The bill requires the CFPB to conduct a cost-benefit analysis for any proposed rule or regulation that is estimated to have an economic impact of $100 million or more.
The CFPB must publish this analysis on its website and provide a detailed explanation of the potential benefits and costs of the proposed rule. Additionally, the bill requires the CFPB to consult with other federal agencies, industry stakeholders, and consumer advocacy groups when conducting these analyses.
The goal of this legislation is to ensure that the CFPB is making informed decisions that take into account the potential economic impact of its regulations. By requiring the CFPB to conduct cost-benefit analyses and make this information publicly available, the bill aims to increase transparency and accountability within the agency. Overall, the Transparency in CFPB Cost-Benefit Analysis Act seeks to promote good governance and ensure that the CFPB is acting in the best interest of consumers and the economy.
The CFPB must publish this analysis on its website and provide a detailed explanation of the potential benefits and costs of the proposed rule. Additionally, the bill requires the CFPB to consult with other federal agencies, industry stakeholders, and consumer advocacy groups when conducting these analyses.
The goal of this legislation is to ensure that the CFPB is making informed decisions that take into account the potential economic impact of its regulations. By requiring the CFPB to conduct cost-benefit analyses and make this information publicly available, the bill aims to increase transparency and accountability within the agency. Overall, the Transparency in CFPB Cost-Benefit Analysis Act seeks to promote good governance and ensure that the CFPB is acting in the best interest of consumers and the economy.
Congressional Summary of HR 7412
Transparency in CFPB Cost-Benefit Analysis Act
This bill sets forth information required to be included in a rulemaking made by the Consumer Financial Protection Bureau (CFPB). Specifically, the CFPB must publish a justification of the proposed rulemaking; a quantitative and qualitative assessment of all anticipated direct and indirect costs and benefits; alternatives to the proposed rulemaking; impacts on small businesses; and any assumptions, data, or studies used in preparing this information.
Read the Full Bill
Current Status of Bill HR 7412
Bill HR 7412 is currently in the status of Bill Introduced since April 6, 2022. Bill HR 7412 was introduced during Congress 117 and was introduced to the House on April 6, 2022. Bill HR 7412's most recent activity was Referred to the House Committee on Financial Services. as of April 6, 2022
Bipartisan Support of Bill HR 7412
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
30Democrat Cosponsors
0Republican Cosponsors
30Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 7412
Primary Policy Focus
Finance and Financial SectorAlternate Title(s) of Bill HR 7412
Transparency in CFPB Cost-Benefit Analysis Act
Transparency in CFPB Cost-Benefit Analysis Act
To enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes.
Comments
Sponsors and Cosponsors of HR 7412
Latest Bills
ACCESS Rural America Act
Bill S 5003July 31, 2026
License to Drill Act
Bill HR 7831July 31, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Health and Human Services relating to "Restoring Flexibility in the Child Care and Development Fund (CCDF)".
Bill SJRES 199July 31, 2026
AGOA Extension Act
Bill HR 6500July 31, 2026
Emergency Conservation Program Improvement Act of 2025
Bill S 629July 31, 2026
Expedited Access to Biosimilars Act
Bill HR 9661July 31, 2026
Expedited Access to Biosimilars Act
Bill S 1414July 31, 2026
Protecting Innocent Taxpayers from Endless Assessments Act
Bill S 4964July 31, 2026
A bill to designate the outdoor amphitheater at the Blue Ridge Music Center in Galax, Virginia, as the "Rick Boucher Amphitheater".
Bill S 815July 31, 2026
SEED Act
Bill HR 5334July 31, 2026
Transparency in CFPB Cost-Benefit Analysis Act
Bill S 4522December 29, 2022





